Khalid Islam

CIK: 0001701858

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

GANX

Gain Therapeutics, Inc.

Director

FENC

FENNEC PHARMACEUTICALS INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

GANX
Gain Therapeutics, Inc.
Jul 15, 2026
Award(A)
Stock Option (right to buy)
Direct
25K shares-
FENC
FENNEC PHARMACEUTICALS INC.
Jun 10, 2026
Award(A)
Stock Option
Direct
25K shares at avg. $8.70-
GANX
Gain Therapeutics, Inc.
Jun 24, 2025
Award(A)
Stock Option (right to buy)
Direct
15K shares-
FENC
FENNEC PHARMACEUTICALS INC.
Jun 3, 2025
Award(A)
Stock Option
Direct
25K shares at avg. $7.88-

		Type	Shares	Price		Ownership
Jul 15, 2026	GANX Gain Therapeutics, Inc.	Award(A) Stock Option (right to buy)	25,000	-	-	Direct
Jun 10, 2026	FENC FENNEC PHARMACEUTICALS INC.	Award(A) Stock Option	25,000	$8.70	-	Direct
Jun 24, 2025	GANX Gain Therapeutics, Inc.	Award(A) Stock Option (right to buy)	15,000	-	-	Direct
Jun 3, 2025	FENC FENNEC PHARMACEUTICALS INC.	Award(A) Stock Option	25,000	$7.88	-	Direct

1-4 of 4 transactions

About Islam Khalid

Islam Khalid (SEC CIK 0001701858) files insider reports with the SEC as Director of Gain Therapeutics, Inc. (GANX) and Director of FENNEC PHARMACEUTICALS INC. (FENC).

Signal8 holds 4 ownership filings by Islam Khalid, all Form 4s, filed between Jun 4, 2025 and Jul 17, 2026. Those filings report 4 transactions, from Jun 3, 2025 to Jul 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Islam Khalid's filings is in BETHESDA, MD.

Recent filings by Islam Khalid

Jul 15, 2026: Grant or award of GANX derivative securities (Form 4, code A).
Jun 10, 2026: Grant or award of FENC derivative securities (Form 4, code A).
Jun 24, 2025: Grant or award of GANX derivative securities (Form 4, code A).
Jun 3, 2025: Grant or award of FENC derivative securities (Form 4, code A).

Other insiders filing for Gain Therapeutics, Inc. (GANX)

How to read Form 4 transaction codes